Awakn Life Sciences will be carrying out the first-ever study investigating the use of ketamine treatment for gambling addiction, using psychedelic-assisted psychotherapy.
The Psychedelic Coalition for Health has launched to educate healthcare professionals in psychedelic-assisted therapy and integration in a bid to meet the growing need for trained...
UK scientists are to research the potential of psilocybin to boost the effects of talking therapies for people with an end-of-life diagnosis.
Awakn Life Sciences has announced the opening of its second psychedelic therapy clinic that will be located in London.
